Drug Profile
R 1647
Alternative Names: R1647Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Major depressive disorder in Switzerland